204 related articles for article (PubMed ID: 32157421)
21. Expression of Immune Checkpoint Receptors on T-Cells and Their Ligands on Leukemia Blasts in Childhood Acute Leukemia.
Kang SH; Hwang HJ; Yoo JW; Kim H; Choi ES; Hwang SH; Cho YU; Jang S; Park CJ; Im HJ; Seo JJ; Kim N; Koh KN
Anticancer Res; 2019 Oct; 39(10):5531-5539. PubMed ID: 31570447
[TBL] [Abstract][Full Text] [Related]
22. Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy.
Fromm G; de Silva S; Johannes K; Patel A; Hornblower JC; Schreiber TH
J Immunother Cancer; 2018 Dec; 6(1):149. PubMed ID: 30563566
[TBL] [Abstract][Full Text] [Related]
23. Expression and prognostic significance of programmed death protein 1 and programmed death ligand-1, and cytotoxic T lymphocyte-associated molecule-4 in hepatocellular carcinoma.
Chang H; Jung W; Kim A; Kim HK; Kim WB; Kim JH; Kim BH
APMIS; 2017 Aug; 125(8):690-698. PubMed ID: 28493410
[TBL] [Abstract][Full Text] [Related]
24. Human leukocyte antigen class II expression is a good prognostic factor in adult T-cell leukemia/lymphoma.
Takeuchi M; Miyoshi H; Asano N; Yoshida N; Yamada K; Yanagida E; Moritsubo M; Nakata M; Umeno T; Suzuki T; Komaki S; Muta H; Furuta T; Seto M; Ohshima K
Haematologica; 2019 Aug; 104(8):1626-1632. PubMed ID: 30630986
[TBL] [Abstract][Full Text] [Related]
25. Modulation of immune checkpoint molecule expression in mantle cell lymphoma.
Harrington BK; Wheeler E; Hornbuckle K; Shana'ah AY; Youssef Y; Smith L; Hassan Q; Klamer B; Zhang X; Long M; Baiocchi RA; Maddocks K; Johnson AJ; Byrd JC; Alinari L
Leuk Lymphoma; 2019 Oct; 60(10):2498-2507. PubMed ID: 30821551
[TBL] [Abstract][Full Text] [Related]
26. Tumor microenvironment of adult T-cell leukemia/lymphoma.
Takeuchi M; Miyoshi H; Ohshima K
J Clin Exp Hematop; 2021; 61(4):202-209. PubMed ID: 34937829
[TBL] [Abstract][Full Text] [Related]
27. Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL).
Xu X; Kalac M; Markson M; Chan M; Brody JD; Bhagat G; Ang RL; Legarda D; Justus SJ; Liu F; Li Q; Xiong H; Ting AT
Cell Death Dis; 2020 Feb; 11(2):94. PubMed ID: 32024820
[TBL] [Abstract][Full Text] [Related]
28. CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.
Yoshida N; Miyoshi H; Kato T; Sakata-Yanagimoto M; Niino D; Taniguchi H; Moriuchi Y; Miyahara M; Kurita D; Sasaki Y; Shimono J; Kawamoto K; Utsunomiya A; Imaizumi Y; Seto M; Ohshima K
J Pathol; 2016 Apr; 238(5):621-6. PubMed ID: 26847489
[TBL] [Abstract][Full Text] [Related]
29. Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma.
Paydas S; Bağır E; Seydaoglu G; Ercolak V; Ergin M
Ann Hematol; 2015 Sep; 94(9):1545-52. PubMed ID: 26004934
[TBL] [Abstract][Full Text] [Related]
30. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
Ohshima K
Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
[TBL] [Abstract][Full Text] [Related]
31. Rapid T-cell lymphoma progression associated with immune checkpoint inhibitors.
Ohmoto A; Fuji S
Expert Rev Hematol; 2023; 16(7):535-541. PubMed ID: 37191476
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of immune checkpoints in the tumour-stromal microenvironment of sebaceous gland carcinoma.
Singh L; Singh MK; Rizvi MA; Pushker N; Bakhshi S; Sen S; Kashyap S
Br J Ophthalmol; 2021 Jan; 105(1):48-56. PubMed ID: 32277010
[TBL] [Abstract][Full Text] [Related]
33. PD-L1, PD-1, LAG-3, and TIM-3 in Melanoma: Expression in Brain Metastases Compared to Corresponding Extracranial Tumors.
Wang JJ; Burger P; Taube J; Soni A; Chaichana K; Sheu M; Belcaid Z; Jackson C; Lim M
Cureus; 2019 Dec; 11(12):e6352. PubMed ID: 31938638
[TBL] [Abstract][Full Text] [Related]
34. Correlation between increased immune checkpoint molecule expression and refractoriness to blinatumomab evaluated by longitudinal T cell analysis.
Kobayashi T; Ubukawa K; Fujishima M; Takahashi N
Int J Hematol; 2021 Apr; 113(4):600-605. PubMed ID: 33387296
[TBL] [Abstract][Full Text] [Related]
35. Potential anti-lymphoma effect of M-CSFR inhibitor in adult T-cell leukemia/lymphoma.
Komohara Y; Noyori O; Saito Y; Takeya H; Baghdadi M; Kitagawa F; Hama N; Ishikawa K; Okuno Y; Nosaka K; Seino KI; Matsuoka M; Suzu S
J Clin Exp Hematop; 2018; 58(4):152-160. PubMed ID: 30541986
[TBL] [Abstract][Full Text] [Related]
36. Programmed Cell Death 1 Ligand 1 and Programmed Cell Death 1 Ligand 2 Are Expressed in Conjunctival Invasive Squamous Cell Carcinoma: Therapeutic Implications.
Wolkow N; Jakobiec FA; Afrogheh AH; Eagle RC; Pai SI; Faquin WC
Am J Ophthalmol; 2019 Apr; 200():226-241. PubMed ID: 30633894
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma.
Chen X; Ma H; Mo S; Zhang Y; Lu Z; Yu S; Chen J
Front Immunol; 2022; 13():942154. PubMed ID: 35936015
[TBL] [Abstract][Full Text] [Related]
38. Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy.
Puntigam LK; Jeske SS; Götz M; Greiner J; Laban S; Theodoraki MN; Doescher J; Weissinger SE; Brunner C; Hoffmann TK; Schuler PJ
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707816
[TBL] [Abstract][Full Text] [Related]
39. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
[TBL] [Abstract][Full Text] [Related]
40. Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms.
Gürler F; Aktürk Esen S; Kurt İnci B; Sütçüoğlu O; Uçar G; Akdoğan O; Uncu D; Turhan N; Akyürek N; Özdemir N; Özet A; Yazıcı O
Cancer Invest; 2024 Feb; 42(2):141-154. PubMed ID: 38486421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
